Login
$NAGE
$2.50 +$0.06 (2.46%) Close

Ownership

13F as of Q2 2026 · 79.1M shares outstanding

Who owns NAGE?

By type of holder
Institutions 40.4% Insiders 12.8% Everyone else 46.9%
Concentration Top 10 holders own 34.7%
Jaksch Frank L Jr 10.6% · BlackRock, Inc. 5.3%
Institutional ownership
40.4%
-6.0 pts vs last qtr
Institutional holders
138
-5 vs last qtr
Net shares bought
−4.7M
by institutions in Q2 2026
New / sold out
23 / 28
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Jacobs Levy Equity Management, Inc NEW +324.7K
  • BlackRock, Inc. +313.0K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Arrowstreet Capital, Limited Partnership −1.2M
  • Renaissance Technologies LLC −669.3K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Niagen Bioscience Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2010–FY2025
+431.2%
+20.39% a year
Each share's claim on the business
−81.2%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
$259K vs $41.6M
over 10 fiscal years
Diluted shares, split-adjusted
15.6M50.9M86.3M2010: 16.1M shares'102011: 25.3M shares'112012: 32.0M shares'122013: 33.5M shares'132020: 61.1M shares'202021: 67.2M shares'212022: 69.7M shares'222023: 75.0M shares'232024: 78.1M shares'242025: 85.4M shares'25
Buybacks Stock-based comp
$0$3.5M$6.9M2010 buybacks: $02010 stock comp: $1.3M'102011 buybacks: $02011 stock comp: $3.0M'112012 buybacks: $8.2K2012 stock comp: $2.7M'122013 buybacks: $02013 stock comp: $1.3M'132020 buybacks: $02020 stock comp: $6.9M'202021 buybacks: $02021 stock comp: $6.2M'212022 buybacks: $02022 stock comp: $5.7M'222023 buybacks: $02023 stock comp: $4.8M'232024 buybacks: $02024 stock comp: $3.7M'242025 buybacks: $251.0K2025 stock comp: $6.1M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years51% 3–5 years5% 1–3 years26% Under 1 year18%
Quarterly turnover
13.1%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting NAGE on Form 13F
B
BlackRock, Inc.
Shares
4.2M
% of company
5.29%
Change vs last qtr
+313.0K (+8.1%)
Held since
≤2021
SW
SteelPeak Wealth, LLC
Shares
3.5M
% of company
4.42%
Change vs last qtr
+127.1K (+3.8%)
Held since
Q1 '26

28 more super investors behind a free account

See every manager holding Niagen Bioscience Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting NAGE on Form N-PORT; together they hold 13.2% of the company
IR
iShares Trust
Position value
$4.75M
% of company
1.88%
% of the fund
0.01%
As of
June 30, 2026
VT
Position value
$4.69M
% of company
1.86%
% of the fund
0.00%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Niagen Bioscience Inc and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
JF
Jaksch Frank L Jr
Insider
Shares
8.4M
% of company
10.58%
Change vs last qtr
—
Held since
—
FR
Fried Robert N
Insider
Shares
1.7M
% of company
2.15%
Change vs last qtr
—
Held since
—

2 more holders behind a free account

See every insider and 5%+ holder of Niagen Bioscience Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support